- 全部删除
您的购物车当前为空
YKL-5-124 是选择性不可逆CDK7共价抑制剂,对CDK7和CDK7/Mat1/CycH 的IC50分别为 53.5 nM 和 9.7 nM。它诱导强烈的细胞周期停滞,并抑制 E2F 驱动的基因表达。它对 CDK7 的生化和细胞选择性优于 CDK12/13。它对CDK7的选择性比 CDK9 和 CDK2 高 100 倍以上。

YKL-5-124 是选择性不可逆CDK7共价抑制剂,对CDK7和CDK7/Mat1/CycH 的IC50分别为 53.5 nM 和 9.7 nM。它诱导强烈的细胞周期停滞,并抑制 E2F 驱动的基因表达。它对 CDK7 的生化和细胞选择性优于 CDK12/13。它对CDK7的选择性比 CDK9 和 CDK2 高 100 倍以上。
| 规格 | 价格 | 库存 | 数量 |
|---|---|---|---|
| 1 mg | ¥ 789 | In stock | |
| 2 mg | ¥ 1,180 | In stock | |
| 5 mg | ¥ 1,990 | In stock | |
| 10 mg | ¥ 3,570 | In stock | |
| 25 mg | ¥ 5,730 | In stock | |
| 50 mg | ¥ 7,820 | In stock | |
| 100 mg | ¥ 10,500 | In stock | |
| 1 mL x 10 mM (in DMSO) | ¥ 2,380 | In stock |
YKL-5-124 相关产品
| 产品描述 | YKL-5-124, a potent, selective and covalent CDK7 inhibitor with an IC50 of 9.7 nM, 1300 nM and 3020 nM for CDK7/Mat1/CycH, CDK2 and CDK9 respectively, displays biochemical and cellular selectivity for CDK7 over CDK12/13. |
| 靶点活性 | CDK7:53.5 nM, CDK9:3020 nM, CDK7-CyclinH-MAT1:9.7 nM, CDK2:1300 nM |
| 分子量 | 515.61 |
| 分子式 | C28H33N7O3 |
| CAS No. | 1957203-01-8 |
| Smiles | CN(C)C[C@@H](NC(=O)N1Cc2c(NC(=O)c3ccc(NC(=O)C=C)cc3)n[nH]c2C1(C)C)c1ccccc1 |
| 密度 | 1.284 g/cm3 (Predicted) |
| 颜色 | White |
| 物理性状 | Solid |
| 存储 | store at low temperature | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||||||||||||
| 溶解度信息 | DMSO: 220 mg/mL (426.68 mM), Sonication is recommended. | |||||||||||||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||||||||||||
DMSO
| ||||||||||||||||||||||||||||||||||||
评论内容